13.89
1.40 (11.21%)
| Penutupan Terdahulu | 12.49 |
| Buka | 12.72 |
| Jumlah Dagangan | 130,444 |
| Purata Dagangan (3B) | 91,459 |
| Modal Pasaran | 369,375,488 |
| Harga / Jualan (P/S) | 6.52 |
| Harga / Buku (P/B) | 2.73 |
| Julat 52 Minggu | |
| Tarikh Pendapatan | 6 Nov 2025 |
| Margin Keuntungan | -76.05% |
| Margin Operasi (TTM) | -56.13% |
| EPS Cair (TTM) | -0.970 |
| Pertumbuhan Hasil Suku Tahunan (YOY) | 100.30% |
| Jumlah Hutang/Ekuiti (D/E MRQ) | 53.19% |
| Nisbah Semasa (MRQ) | 6.48 |
| Aliran Tunai Operasi (OCF TTM) | -26.21 M |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Health Information Services (US) | Bercampur | Menurun |
| Health Information Services (Global) | Bercampur | Menurun | |
| Stok | Carlsmed, Inc. | Menaik | - |
AISkor Stockmoo
| Konsensus Penganalisis | 3.5 |
| Aktiviti Orang Dalam | NA |
| Volatiliti Harga | -1.0 |
| Purata Bergerak Teknikal | 2.5 |
| Osilator Teknikal | -0.5 |
| Purata | 1.13 |
|
Carlsmed Inc is a commercial-stage medical technology company pioneering AI-enabled personalized spine surgery solutions with a mission to improve outcomes and decrease the cost of healthcare for spine surgery and beyond. It is focused on becoming the standard of care for spine fusion surgery. The aprevo Technology Platform consists of AI-enabled software solutions, and interbody implants that it custom design for each patient’s unique pathology and vertebral bone topography, and single-use surgical instruments. The Company designs, manufactures, and markets aprevo, a comprehensive technology platform for spine fusion surgery procedures. |
|
| Sektor | Healthcare |
| Industri | Health Information Services |
| % Dimiliki oleh Orang Dalam | 4.06% |
Pemilikan
| Nama | Tarikh | Syer Dipegang |
|---|---|---|
| Burkehill Global Management, Lp | 30 Sep 2025 | 50,000 |
| Julat 52 Minggu | ||
| Median | 24.00 (72.79%) | |
| Jumlah | 1 Beli | |
| Syarikat | Tarikh | Harga Sasaran | Panggilan | Harga @ Panggilan |
|---|---|---|---|---|
| BTIG | 15 Dec 2025 | 24.00 (72.79%) | Beli | 12.91 |
Tiada data dalam julat masa ini.
| Tarikh | Jenis | Butiran |
|---|---|---|
| 12 Jan 2026 | Pengumuman | Carlsmed Announces Preliminary Revenue for the Fourth Quarter and Full Year 2025 |
| 06 Jan 2026 | Pengumuman | Carlsmed aprevo® Lumbar 2-year Data Published in Global Spine Journal |
| 16 Dec 2025 | Pengumuman | Carlsmed, Inc. To Participate in the J.P. Morgan 2026 Healthcare Conference |
| 03 Dec 2025 | Pengumuman | Carlsmed Announces U.S. Launch of its aprevo® Technology Platform for Cervical Fusion Surgeries at the Cervical Spine Research Society (CSRS) 53rd Annual Meeting |
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2026 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |